Your browser doesn't support javascript.
loading
Response to John et al's comments of "paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the prospective rosacea refractory erythema randomized clinical trial".
Wang, Ben; Huang, Yingxue; Li, Ji.
Afiliação
  • Wang B; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratary of Aging Biology, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Huang Y; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratary of Aging Biology, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li J; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratary of Aging Biology, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: liji_xy@csu.edu.cn.
J Am Acad Dermatol ; 90(4): e143-e144, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38049068

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroxetina / Rosácea Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroxetina / Rosácea Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article